Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Operating Income

Operating Income at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$93M-75.7%
AptarGroup logo
AptarGroupATR
$107.5M-5.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$184.52M+30.4%
AVT
AvantorAVTR
$99.5M-32.5%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-$3.13M-342%
Sonoco Products logo
Sonoco ProductsSON
$127.09M+0.2%

Segments

By segment

See full
Proprietary Products$189.2M+44.9%
West Vantage$15.6M—

Other financials

Income statement

See full
Revenue$844.9M+21.0%
Gross profit$296.4M+27.8%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$25.36B+64.2%
Enterprise value$25.16B+65.1%
P/E46.7×+15.1×
P/S7.9×+2.7×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's operating income?
West Pharmaceutical Services (WST) reported operating income of $177.1M in Q1 2026.
How has West Pharmaceutical Services's operating income changed year-over-year?
West Pharmaceutical Services's operating income increased by 65.5% year-over-year, from $107M to $177.1M.
What is the long-term trend for West Pharmaceutical Services's operating income?
Over 4 years (2021 to 2025), West Pharmaceutical Services's operating income has grown at a -6.1% compound annual growth rate (CAGR), from $752.3M to $584.9M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.